We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
+6.06%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$1.28B
AUM Growth
+$142M
Cap. Flow
+$97.5M
Cap. Flow %
7.64%
Top 10 Hldgs %
60.95%
Holding
46
New
10
Increased
10
Reduced
13
Closed
7

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$45.9M
2
LH icon
Labcorp
LH
+$34.8M
3
CYH icon
Community Health Systems
CYH
+$30M
4
THC icon
Tenet Healthcare
THC
+$26.5M
5
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$23.2M

Top Sells

Rank Stock Value
1
VTRS icon
Viatris
VTRS
+$72.8M
2
MRK icon
Merck
MRK
+$49.6M
3
A icon
Agilent Technologies
A
+$28.6M
4
UNH icon
UnitedHealth
UNH
+$26.3M
5
EW icon
Edwards Lifesciences
EW
+$23M

Sector Composition

Rank Sector Weight
1 Healthcare 71.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$771B
$234M 18.32%
+1,250,000
New +$229M
TEVA icon
2
Teva Pharmaceuticals
TEVA
$40.4B
$87.2M 6.83%
1,650,000
-350,000
-18% -$16.2M
ELV icon
3
Elevance Health
ELV
$81.5B
$79.6M 6.24%
800,000
– –
THC icon
4
Tenet Healthcare
THC
$22.2B
$72.8M 5.7%
1,700,000
+600,000
+55% +$26.5M
DGX icon
5
Quest Diagnostics
DGX
$26B
$63.7M 4.99%
1,100,000
+300,000
+38% +$16.1M
CNMD icon
6
CONMED
CNMD
$1.3B
$60.2M 4.72%
1,385,000
– –
CYH icon
7
Community Health Systems
CYH
$382M
$49M 3.84%
1,512,500
+907,500
+150% +$30M
VOLC
8
DELISTED
VOLCANO CORPORATION COM STK
VOLC
$48.3M 3.78%
2,450,000
+100,000
+4% +$2.14M
HCA icon
9
HCA Healthcare
HCA
$88.4B
$42M 3.29%
800,000
-450,000
-36% -$22.4M
MNK
10
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$41.2M 3.23%
650,000
-350,000
-35% -$22.1M
HAE icon
11
Haemonetics
HAE
$3.88B
$39.2M 3.07%
+1,202,000
New +$45.9M
LH icon
12
Labcorp
LH
$25.2B
$36.8M 2.89%
+436,500
New +$34.8M
MASI
13
DELISTED
Masimo
MASI
$34.8M 2.73%
1,275,000
-150,000
-11% -$4.28M
HOLX
14
DELISTED
Hologic
HOLX
$32.3M 2.53%
1,500,000
– –
UAM
15
DELISTED
Universal American Corp
UAM
$29.5M 2.32%
4,178,259
+1,678,259
+67% +$11.9M
UNH icon
16
UnitedHealth
UNH
$382B
$24.6M 1.93%
300,000
-350,000
-54% -$26.3M
ARIA
17
DELISTED
Ariad Pharmaceuticals Inc
ARIA
$24.2M 1.89%
3,000,000
-2,250,000
-43% -$17.5M
HRC
18
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$23.1M 1.81%
+600,000
New +$23.2M
ABT icon
19
Abbott
ABT
$187B
$23.1M 1.81%
+600,000
New +$23.1M
HUM icon
20
Humana
HUM
$43.9B
$22.5M 1.77%
200,000
-200,000
-50% -$20.8M
KERX
21
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$21.3M 1.67%
+1,250,000
New +$18.9M
AMRN
22
Amarin Corp
AMRN
$297M
$19.9M 1.56%
550,000
+125,000
+29% +$4.65M
GHDX
23
DELISTED
Genomic Health, Inc.
GHDX
$19.8M 1.55%
+750,000
New +$21.5M
BLUE
24
DELISTED
bluebird bio
BLUE
$16.1M 1.26%
54,573
+38,600
+242% +$11.7M
FURX
25
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
$13.1M 1.02%
+150,000
New +$11.6M
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Camber Capital Management held 46 positions worth $1.28B, up 13% from $1.13B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Camber Capital Management deployed $97.5M of net new capital in Q1 2014, opening 10 new positions and adding to 10 existing holdings. Its largest new stake was Haemonetics: 1,202,000 shares worth $39.2M.

By sector, the portfolio is most concentrated in Healthcare at 71% of assets, down from 85% a quarter earlier.

On the sell side, the largest reduction was Viatris, an estimated $72.8M trimmed.

  • Camber Capital Management's largest Q1 2014 buy was Haemonetics: 1,202,000 shares worth $39.2M.
  • Camber Capital Management added most to Community Health Systems in Q1 2014, an estimated $30M increase.
  • Camber Capital Management's biggest Q1 2014 reduction was Viatris, cutting an estimated $72.8M.
  • Camber Capital Management fully exited Merck in Q1 2014, selling an estimated $49.6M.
  • Camber Capital Management's ten largest holdings make up 61% of its $1.28B portfolio in Q1 2014.
  • Camber Capital Management opened 10 new positions and closed 7 in Q1 2014.
  • Camber Capital Management's portfolio value rose 13% quarter-over-quarter to $1.28B.

Based on Camber Capital Management's 13F filing for Q1 2014, filed 15 May 2014.